News Nuvation Bio Inc.

Equities

NUVB

US67080N1019

Real-time Estimate Cboe BZX Other stock markets 12:12:10 2024-05-09 pm EDT			5-day change	1st Jan Change
3.345 ^USD	+3.88%		+1.68%	+120.20%

Apr. 17	RBC Raises Price Target on Nuvation Bio to $5 From $4, Keeps Outperform, Speculative Risk	MT
Apr. 10	Nuvation Bio Closes Acquisition of AnHeart Therapeutics	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology Annual Meeting	Apr. 25	AQ
Nuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	Apr. 24	BU
RBC Raises Price Target on Nuvation Bio to $5 From $4, Keeps Outperform, Speculative Risk	Apr. 17	MT
Nuvation Bio Closes Acquisition of AnHeart Therapeutics	Apr. 10	MT
Nuvation Bio : Acquisition/Asset Disposal - Form 8-K	Apr. 10	PU
Nuvation Bio Inc. Announces Appointment of Directors	Apr. 10	CI
Nuvation Bio Completes Acquisition of AnHeart Therapeutics	Apr. 10	BU
Nuvation Bio Inc. completed the acquisition of AnHeart Therapeutics Ltd	Apr. 08	CI
HC Wainwright Adjusts Nuvation Bio's Price Target to $8 From $5, Maintains Buy Rating	Mar. 28	MT
Nuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial Officer	Mar. 28	BU
Nuvation Bio Inc. Appoints Colleen Sjogren as Chief Commercial Officer	Mar. 28	CI
North American Morning Briefing : Stocks Set for -2-	Mar. 28	DJ
Nuvation Bio Shares Jump After Jefferies Upgrade	Mar. 27	MT
Thinking about buying stock in BigBear.ai, Bitfarms, Paysign, Nuvation Bio, or One Group Hospitality?	Mar. 27	PR
Top Premarket Gainers	Mar. 27	MT
Jefferies Upgrades Nuvation Bio to Buy From Hold, Adjusts Price Target to $10 From $1.40	Mar. 27	MT
North American Morning Briefing : Stocks Edge -2-	Mar. 27	DJ
BTIG Upgrades Nuvation Bio to Buy From Neutral, Price Target is $5	Mar. 26	MT
Nuvation Bio Agrees to Acquire AnHeart Therapeutics in All-Stock Deal -- Shares Fall	Mar. 25	MT
Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction	Mar. 25	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Nuvation Bio Inc.

Equities

NUVB

US67080N1019

Summary

Filters